ClinicalTrials.Veeva

Menu

Combined Effect of Scapulothoracic Mobilization With Buteyko Breathing on COPD (Chronic Obstructive Pulmonary Disease) Patients

R

Rashid Latif Medical College

Status

Completed

Conditions

Chronic Obstructive Pulmonary Disease

Treatments

Other: Scapulothoracic mobilization
Other: Buteyko breathing

Study type

Interventional

Funder types

Other

Identifiers

NCT07106086
IRB/2023/130

Details and patient eligibility

About

The objective of this study will be to determine the combine effect of scapulothoracic mobilization with Buteyko breathing on pulmonary parameters functional capacity and balance among COPD patient.

Full description

The study will be Randomized Clinical Trial which include forty (40) subjects clinically diagnosed according to Global Initiative for Obstructive Lung Disease (GOLD) standard of chronic obstructive pulmonary disease (COPD). Patients will be allocated into two groups i.e. Group A (20) and Group B (20). Group A scapulothoracic mobilization with Buteyko breathing (BBT) and Group B received Buteyko breathing (BBT). The Pulse oximeter will be used to evaluate Pulmonary parameters. The 6-meter walk test will be used to assess functional capacity. The Activities-specific balance confidence scale (ABC scale) will be used to assess Balance Confidence and Single leg stance (SLS) will be used to evaluate balance. The evaluation will be done on day one as pretreatment values and post-treatment values at the end of third week.

Enrollment

40 patients

Sex

All

Ages

40 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Clinically Diagnosed COPD is confirmed by diagnostic criteria of COPD (forced expiratory volume in 1 second [FEV1] <80% predicted, FEV1/forced vital capacity [FVC] <0.7 predicted) according to the international guideline and the ability to provide inform consent.
  • Patients with Resting Respiratory Rate >_ 24

Exclusion Criteria

  • Patients diagnosed with a primary pulmonary vascular disease
  • Patients diagnosed with severe psychiatric disorders and cognitive dysfunction
  • Patients diagnosed severe auditory/visual impairments
  • Patients diagnosed Musculoskeletal, Rheumatic ,Cardiac/Neurological disorder and Malignancies
  • Patients diagnosed with skin, peripheral vascular disorder excluded

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Scapulothoracic mobilization with buteyko breathing
Experimental group
Description:
Scapulothoracic mobilization with buteyko breathing
Treatment:
Other: Buteyko breathing
Other: Scapulothoracic mobilization
Buteyko breathing
Active Comparator group
Description:
buteyko breathing
Treatment:
Other: Buteyko breathing

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems